Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| MDS-UPDRS× | UHDRS: Vienotā Hantingtona slimības vērtēšanas skala× | |
|---|---|---|
| Nozare | Neiroloģija | Neiroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 2008 | 1996 |
| Autors≠ | Christopher G. Goetz and Movement Disorder Society | Huntington Study Group |
| Tips≠ | Clinician-rated | Clinician-rated and performance-based |
| Pirmavots≠ | Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗ | Huntington Study Group (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136-142. link ↗ |
| Citi nosaukumi≠ | UPDRS | UHDRS, Huntington's Rating Scale |
| Saistītās≠ | 5 | 4 |
| Kopsavilkums≠ | The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice. | The Unified Huntington's Disease Rating Scale (UHDRS) is the comprehensive, multidomain assessment instrument for Huntington's disease, a neurodegenerative disorder caused by expanded CAG trinucleotide repeats. Developed by the Huntington Study Group in 1996, the UHDRS measures motor, cognitive, functional, and psychiatric manifestations of disease. The UHDRS is the gold-standard outcome measure in Huntington's disease clinical trials and longitudinal natural history studies. |
| ScholarGateDatu kopa ↗ |
|
|